Skip to main content

Advertisement

SpringerLink
Log in

Between reduction of glucose fluctuations and increased therapeutic adherence: an example of the benefits of vildagliptin in an elderly diabetic patient

  • Case Report
  • Published:
Aging Clinical and Experimental Research Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Bruno G, De Micheli A, Frontoni S, Monge L, Società Italiana di Diabetologia-Associazione Medici Diabetologi (SID-AMD) Working Group on the Standards of Care for Diabetes (2011) Highlights from “Italian Standards of care for Diabetes Mellitus 2009-2010”. Nutr Metab Cardiovasc Dis 21(4):302–314

    CAS  PubMed  Google Scholar 

  2. Budnitz DS, Lovegrove MC, Shehab N, Richards CL (2011) Emergency hospitalizations for adverse drug events in older Americans. N Engl J Med 365:2002–2012

    Article  CAS  PubMed  Google Scholar 

  3. Rizzo MR, Barbieri M, Marfella R, Paolisso G (2012) Reduction of oxidative stress and inflammation by blunting daily acute glucose fluctuations in patients with type 2 diabetes: role of dipeptidyl peptidase-IV inhibition. Diabetes Care 35(10):2076–2082

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  4. Monnier L, Wojtusciszyn A, Colette C, Owens D (2011) The contribution of glucose variability to asymptomatic hypoglycemia in persons with type 2 diabetes. Diabetes Technol Ther 13(8):813–818

    Article  CAS  PubMed  Google Scholar 

  5. Rizzo MR, Marfella R, Barbieri M, Boccardi V, Vestini F, Lettieri B, Canonico S, Paolisso G (2010) Relationships between daily acute glucose fluctuations and cognitive performance among aged type 2 diabetic patients. Diabetes Care 33(10):2169–2174

    Article  PubMed Central  PubMed  Google Scholar 

  6. He YL, Foteinos G, Neelakantham S, Mattapalli D, Kulmatycki K, Forst T, Taylor A (2013) Differential effects of vildagliptin and glimepiride on glucose fluctuations in patients with type 2 diabetes mellitus assessed using continuous glucose monitoring. Diabetes Obes Metab 15(12):1111–1119

    Article  CAS  PubMed  Google Scholar 

Download references

Conflict of interest

No potential conflicts of interest relevant to this article were reported.

Author information

Authors and Affiliations

  1. Department of Medicine, University of Padova, Via Giustiniani 2, 35128, Padua, Italy

    N. C. Chilelli, S. Burlina, G. Sartore & A. Lapolla

Authors
  1. N. C. Chilelli
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S. Burlina
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. G. Sartore
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. A. Lapolla
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to A. Lapolla.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Chilelli, N.C., Burlina, S., Sartore, G. et al. Between reduction of glucose fluctuations and increased therapeutic adherence: an example of the benefits of vildagliptin in an elderly diabetic patient. Aging Clin Exp Res 27, 85–87 (2015). https://doi.org/10.1007/s40520-014-0235-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40520-014-0235-x

Keywords

Search

Navigation